Vor Biopharma stockholders elect three Class I directors and ratify E&Y as auditor

Vor Biopharma Inc.

Stockholders elected Matthew Patterson, Daniella Beckman, and Kush Parmar as Class I directors for terms until 2025.
Ratification of Ernst & Young LLP as independent auditor for FY2022: 28,763,851 votes for, 3,220 against, 2,428 abstain.
Approximately 76.69% of eligible shares were represented at the Annual Meeting.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.